BIOLINERX LTD-SPONS ADR (BLRX)

US09071M2052 - ADR

0.68  +0.02 (+3.01%)

After market: 0.7 +0.02 (+2.94%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
4.80M0.000.000.000.00
Cost Of Goods
3.69MN/AN/AN/AN/A
Gross Profit
1.11MN/AN/AN/AN/A
Operating Expenses
44.10M29.16M24.78M22.93M28.11M
Research and Development
11.94M17.01M18.81M17.31M22.58M
Selling, General, and Administrative Expenses
31.23M11.49M5.27M4.68M4.59M
Operating Income
-42.99M-29.16M-24.78M-22.93M-28.11M
Interest Income/Expense
-101.00K-1.46M-447.00K-1.39M3.16M
Other Income/Expense
-10.82M5.67M-1.83M-5.70M-493.00K
Non Recurring Items
-6.70MN/AN/AN/AN/A
Income Before Taxes
-60.61M-24.95M-27.05M-30.02M-25.45M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-60.61M-24.95M-27.05M-30.02M-25.45M
EBITDA
-41.61M-28.50M-24.07M-21.99M-27.17M
 
Per Share Data
EPS Diluted Total Ops
-0.85-0.43-0.55-1.60-2.34
 
Statistics
Gross Profit Margin
23.08%N/AN/AN/AN/A
Profit Margin
-1262.79%N/AN/AN/AN/A
Operating Profit Margin
-895.65%N/AN/AN/AN/A

All data in USD

Charts